The solution structure of a chimeric LEKTI domain reveals a chameleon sequence

Biochemistry

Volumn 43, Issue 35, 2004, Pages 11238-11247

  Tidow, Henning ^a   Lauber, Thomas ^a   Vitzithum, Klaus ^a   Sommerhoff, Christian P ^b   Rösch, Paul ^a   Marx, Ute C ^a  

^a UNIVERSITY OF BAYREUTH   (Germany)

^b UNIVERSITY OF MUNICH   (Germany)

Author keywords

[No Author keywords available]

Indexed keywords

PROTEIN SEQUENCES; STRUCTURAL FEATURES;

AMINO ACIDS; CONFORMATIONS; ENZYME INHIBITION; NUCLEAR MAGNETIC RESONANCE SPECTROSCOPY;

PROTEINS;

AMYLOID; CHIMERIC PROTEIN; ISOLEUCINE; PHENYLALANINE; PROLINE; PROTEIN LEKT1; PROTEINASE INHIBITOR; SERINE PROTEINASE; UNCLASSIFIED DRUG;

ALPHA HELIX; AMINO ACID SEQUENCE; ARTICLE; CARBOXY TERMINAL SEQUENCE; CHAMELEON SEQUENCE; CHIMERA; CONFORMATIONAL TRANSITION; ESCHERICHIA COLI; NONHUMAN; PRIORITY JOURNAL; PROTEIN CONFORMATION; PROTEIN FOLDING; PROTEIN INTERACTION; PROTEIN SECONDARY STRUCTURE; PROTEIN STRUCTURE; RESIDUE ANALYSIS; SEQUENCE ANALYSIS; STATISTICAL SIGNIFICANCE; STRUCTURE ANALYSIS; SUBSTITUTION REACTION; THREE DIMENSIONAL IMAGING;

AMINO ACID SEQUENCE; CARRIER PROTEINS; CRYSTALLOGRAPHY, X-RAY; ESCHERICHIA COLI PROTEINS; GENES, SYNTHETIC; HUMANS; HYDROLYSIS; MOLECULAR SEQUENCE DATA; NUCLEAR MAGNETIC RESONANCE, BIOMOLECULAR; OLIGOPEPTIDES; PLASMIN; PROTEIN FOLDING; PROTEIN STRUCTURE, SECONDARY; PROTEIN STRUCTURE, TERTIARY; PROTEINS; RECOMBINANT FUSION PROTEINS; SOLUTIONS; SUBTILISINS; TRYPSIN INHIBITORS;

ESCHERICHIA COLI; NEGIBACTERIA;

EID: 4444340508     PISSN: 00062960     EISSN: None     Source Type: Journal    
DOI: 10.1021/bi0492399     Document Type: Article

References (60)

1. Haber, E., and Anfinsen, C. B. (1961) Regeneration of enzyme activity by air oxidation of reduced subtilisin-modified ribonuclease, J. Biol. Chem. 236, 422-424.
2. Anfinsen, C. B. (1973) Principles that govern the folding of protein chains. Science 181, 223-230.
3. Mezei, M. (1998) Chameleon sequences in the PBD, Protein Eng. 11, 411-414.
4. Minor, D. L., Jr., and Kim, P. S. (1996) Context-dependent secondary structure formation of a designed protein sequence, Nature 380, 730-734.
5. 26-Ala, Protein Sci. 7, 1875-1883.
6. Abel, K., Yoder, M. D., Hilgenfeld, R., and Jurnak, F. (1996) An α to β conformational switch in EF-Tu, Structure 4, 1153-1159.
7. Carr, C. M., and Kim, P. S. (1993) A spring-loaded mechanism for the conformational change of influenza hemagglutinin, Cell 73, 823-832.
8. Harrison, P. M., Bamborough, P., Daggett, V., Prusiner, S. B., and Cohen, F. E. (1997) The prion folding problem, Curr. Opin. Struct. Biol. 7, 53-59.
9. Prusiner, S. B. (1994) Molecular biology and genetics of prion disease, Philos. Trans. R. Soc. London, Ser. B 343, 447-463.
10. Mägert, H. J., Ständker, L., Kreutzmann, P., Zucht, H. D., Reinecke, M., Sommerhoff, C. P., Fritz, H., and Forssmann, W. G. (1999) LEKTI, a novel 15-domain type of serine proteinase inhibitor. J. Biol. Chem. 274, 21499-21502.
11. Chavanas, S., Garner, C., Bodemer, C., Ali, M., Hamel-Teillac, D., Wilkinson, J., Bonafe, J. L., Paradisi, M., Kelsell, D. P., Ansai, S., Mitsuhashi, Y., Larregue, M., Leigh, I. M., Harper, J. I., Taieb, A., de Prost, Y., Cardon, L. R., and Hovnanian, A. (2000) Localization of the Netherton syndrome gene to chromosome 5q32, by linkage analysis and homozygosity mapping, Am. J. Hum. Genet. 66, 914-921.
12. Walley, A. I., Chavanas, S., Moffatt, M. F., Esnouf, R. M., Ubhi, B., Lawrence, R., Wong, K., Abecassis, G. R., Jones, E. Y., Harper, J. I., Hovnanian, A., and Cookson, W. O. (2001) Gene polymorphism in Netherton and common atopic disease, Nat. Genet. 29, 175-178.
13. Sprecher, E., Chavanas, S., DiGiovanna, J. J., Amin, S., Nielsen, K., Prendiville, J. S., Silverman, R., Esterly, N. B., Spraker, M. K., Guelig, E., de Luna, M. L., Williams, M. L., Buehler, B., Siegfried, E. C., Van Maldergem, L., Pfendner, E., Bale, S. J., Uitto, J., Hovnanian, A., and Richard, G. J. (2001) The spectrum of pathogenic mutations in SPINK5 in 19 families with Netherton syndrome: implications for mutation detection and first case of prenatal diagnosis, Invest. Dermatol. 117, 179-187.
14. Komatsu, N., Takata, M., Otsuki, N., Ohka, P., Amano, O., Takehara, K., and Saijoh, K. (2002) Elevated stratum corneum hydrolytic activity in Netherton syndrome suggests an inhibitory regulation of desquamation by SPINK5-derived peptides, J. Invest. Dermatol. 118, 436-443.
15. Bitoun, E., Bodemer, C., Amiel, J., de Prost, Y., Stoll, C., Calvas, P., and Hovnanian, A. (2002) Prenatal diagnosis of a lethal form of Netherton syndrome by SPINK5 mutation analysis, Prenatal Diagn. 22, 121-126.
16. Mägert, H. J., Kreuzmann, P., Ständker, L., Walden, M., Drögemüller, K., and Forssmann, W. G. (2002) LEKTI: a multidomain serine proteinase inhibitor with pathophysiological relevance, Int. J. Biochem. Cell Biol. 34, 573-576.
17. Mägert, H. J., Kreuzmann, P., Drögemüller, K., Ständker, L., Adermann, K., Walden, M., John, H., Korting, H. C., and Forssmann, W. G. (2002) The 15-domain serine proteinase inhibitor LEKTI: biochemical properties, genomic organization, and pathophysical role, Eur. J. Med. Res. 7, 49-56.
18. pro) structure: basis for design of anti-SARS drugs, J. Protein Chem. 20, 273-278.
19. Lauber, T., Schulz, A., Schweimer, K., Adermann, K., and Marx, U. C. (2003) Homologous proteins with different folds: the three-dimensional structures of domains 1 and 6 of the multiple Kazal-type inhibitor LEKTI, J. Mol. Biol. 328, 205-219.
20. Lauber, T., Marx, U. C., Schulz, A., Kreutzmann, P., and Rösch, P. (2001) Accurate disulfide formation in Escherichia coli: overexpression and characterization of the first domain (HF6478) of the multiple Kazal-type inhibitor LEKTI, Protein Expression Purif. 22, 108-112.
21. Derman, A. I., Prinz, W. A., Belin, D., and Beckwith, J. (1993) Mutations that allow disulfide bond formation in the cytoplasm of Escherichia coli, Science 262, 1744-1747.
22. Prinz, W. A., Aslund, F., Holmgren, A., and Beckwith, J. (1997) The role of the thioredoxin and glutaredoxin pathways in reducing protein disulfide bonds in the Escherichia coli cytoplasm, J. Biol. Chem. 272, 15661-15667.
23. Porath, J. (1992) Immobilized metal ion affinity chromatography, Protein Expression Purif. 3, 263-281.
24. Sambrook, J., Fritsch, E. F., and Maniatis, M. (1989) Molecular cloning: a laboratory manual, Cold Spring Harbor Laboratory Press, Plainview, NY.
25. Talluri, S., and Wagner, G. (1996) An Optimized 3D NOESY-HSQC, J. Magn. Reson., Ser. B 112, 200-205.
26. Cavanagh, J., Fairbrother, W. J., Palmer, A. G., III, and Skelton, N. J. (1996) Protein NMR Spectroscopy, Academic Press, San Diego.
27. 1H groups with pulsed field gradients and preservation of coherence pathways, J. Magn. Reson., Ser. A 111, 121-126.
28. Johnson, B. A., and Blevins, R. A. (1994) NMRView: A computer program for the visualization and analysis of NMR data, J. Biomol. NMR 4, 603-614.
29. Friedrichs, M. (1995) A model-free algorithm for the removal of baseline artefacts, J. Biomol. NMR 5, 147-153.
30. Markley, J. L., Bax, A., Arata, Y., Hilbers, C. W., Kaptein, R., Sykes, B. D., Wright, P. E., and Wüthrich, K. (1998) Recommendations for the presentation of NMR structures of proteins and nucleic acids, Pure Appl. Chem. 70, 117-142.
31. Brünger, A. T. (1993) X-PLOR version 3.1: A system for X-ray crystallography and NMR, Howard Hughes Medical Institute and Yale University Press, New Haven, CT.
32. 1H NMR, Proteins: Struct., Funct., Genet. 17, 297-309.
33. Holak, T. A., Nilges, M., and Oschkinat, H. (1989) Improved strategies for the determination of protein structures from NMR data: the solution structure of acyl carrier protein, FEBS Lett. 242, 649-654.
34. Neudecker, P., Sticht, H., and Rösch, P. (2001) Improving the efficiency of the Gaussian conformational database potential for the refinement of protein and nucleic acid structures, J. Biomol. NMR 21, 373-375.
35. Kuszewski, J., and Clore, G. M. (2000) Sources of and solutions to problems in the refinement of protein NMR structures against torsion angle potentials of mean force, J. Magn. Reson. 146, 249-254.
36. Koradi, R., Billeter, M., and Wüthrich, K. (1996) MOLMOL: a program for display and analysis of macromolecular structures, J. Mol. Graphics 14, 51-55.
37. Laskowski, R. A., MacArthur, M. W., Moss, D. S., and Wright, P. E. (1993) PROCHECK: a program to check the stereochemical quality of protein structures, J. Appl. Crystallogr. 26, 283-291.
38. Wüthrich, K. (1986) NMR of Proteins and Nucleic Acids, John Wiley & Sons, New York.
39. 15N inverse detected heteronuclear NMR spectroscopy: application to staphylococcal nuclease, Biochemistry 28, 8972-8979.
40. Wishart, D. S., Sykes, B. D., and Richards, F. M. (1991) Relationship between nuclear magnetic resonance chemical shift and protein secondary structure, J. Mol. Biol. 222, 311-333.
41. Shoemaker, K. R., Kim, P. S., York, E. J., Stewart, J. M., and Baldwin, R. L. (1987) Tests of the helix dipole model for stabilization of α-helices, Nature 326, 563-567.
42. Kreutzmann, P., Schulz, A., Ständker, L., Forssmann, W.-G., and Mägert, H. J. (2004) Recombinant production, purification and biochemical characterization of domain 6 of LEKTI: a temporary Kazal-type-related serine proteinase inhibitor. J. Chromatogr., B: Anal. Technol. Biomed. Life Sci. 803, 75-81.
43. Mitsudo, K., Jayakumar, A., Henderson, Y., Frederick, M. J., Kang, Y., Wang, M., El-Naggar, A. K., and Clayman, G. L. (2003) Inhibition of serine proteinases plasmin, trypsin, subtilisin A, cathepsin G, and elastase by LEKTI: a kinetic analysis. Biochemistry 42, 3874-3881.
44. Jayakumar, A., Kang, Y., Mitsudo, K., Henderson, Y., Frederick, M. J., Wang, M., El-Naggar, A. K., Marx, U. C., Briggs, K., and Clayman, G. L. (2004) Expression of LEKTI domains 6-9′ in the baculovirus expression system: recombinant LEKTI domains 6-9′ inhibit trypsin and subtilisin A. Protein Expression Purif. 35, 93-101.
45. Bode, W., Wei, A.-Z., Huber, R., Meyer, E., Travis, J., and Neumann, S. (1986) X-ray crystal structure of the complex of human leukocyte elastase (PMN elastase) and the third domain of the turkey ovomucoid inhibitor, EMBO J. 5, 2453-2458.
46. Bode, W., and Huber, R. (1992) Natural protein proteinase inhibitors and their interaction with proteinases, Eur. J. Biochem. 204, 433-451.
47. Bode, W., and Huber, R. (2000) Structural basis of the endoproteinase-protein inhibitor interaction, Biochim. Biophys. Acta 1477, 241-252.
48. Laskowski, M., Jr. (1998) http://www.chem.purdue.edu/LASKOWSKI/#data.
49. Jackson, R. M. (1999) Comparison of protein-protein interactions in serine protease-inhibitor and antibody-antigen complexes: implications for the protein docking problem, Protein Sci. 8, 603-613.
50. Lu, W., Apostol, I., Qasim, M. A., Warne, N., Wynn, R., and Zhang, W. L. (1997) Binding of amino acids side-chains to SI cavities of serine proteases, J. Mol. Biol. 266, 441-461.
51. Fujinaga, M., Huang, K., Bateman, K. S., and James, M. N. (1998) Computational analysis of the binding of PI variants of domain 3 of turkey ovomucoid inhibitor to Streptomyces griseus protease B. J. Mol. Biol. 284, 1683-1694.
52. Helland, R., Otlewski, J., Sundheim, O., Dadlez, M., and Smalas, A. O. (1999) The crystal structures of the complexes between bovine β-trypsin and ten P1 variants of BPTI, J. Mol. Biol. 287, 923-942.
53. Dalal, S., Balasabramanian, S., and Regan, L. (1997) Protein alchemy: Changing β-sheet into α-helix, Nat. Struct. Biol. 4, 548-551.
54. Munoz, V., and Serrano, L. (1994) Elucidating the folding problem of α-helical peptides using empirical parameters II. Helix macrodipole effects and rational modification of the helical content of natural peptides, J. Mol. Biol. 245, 275-296.
55. Daggett, V., and Fersht, A. R. (2003) Is there a unifying mechanism for protein folding? Trends Biochem. Sci. 28, 18-25.
56. Sagermann, M., Gay, L., and Metthews, B. W. (2003) Long-distance conformational changes in a protein engineered by modulated sequence duplication, Proc. Natl. Acad. Sci. U.S.A. 100, 9191-9195.
57. Ikeda, K., Galzitskaya, O. V., Nakamura, H., and Higo, J. (2003) β-Hairpins, α-helices, and the intermediates among the secondary structures in the energy landscape of a peptide from a distal β-hairpin of SH3 domain, J. Comput. Chem. 24, 310-318.
58. Dobson, C. M. (2001) The structural basis of protein folding and its links with human disease, Philos. Trans. R. Soc. London, Ser. B 356, 133-145.
59. Riek, R., Homemann, S., Wider, G., Billeter, M., Glockshuber, R., and Wüthrich, K. (1996) NMR structure of the mouse prion protein domain PrP (121-231), Nature 382, 180-182.
60. Young, K., Piccardo, P., Dloughy, S., Bugiani, O., Tagliavini, F., and Ghetti, B. (1999) The Human Genetic Prion Diseases, in Prions: Mnolecular and Cellular Biology (Harris, D. A., Ed.) pp 139-175, Horizon Scientific Press, Wymondham, U.K.